Furthermore, RNA sequencing revealed a strong activation of TNF-dependent signaling pathways in non-remitters to VDZ treatment, thereby providing first evidence that anti-TNF therapy might be therapeutically effective in IBD patients with VDZ failure. The gene discussed is TNF; the disease is inflammatory bowel disease.